• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 551

Substance: Aspartic protease derived from the flowers of Cynera cardunculus L.
Intended Use: For use as a coagulant in the production of cheese and cheese products.
Basis: Scientific procedures
Notifier: Fytozimus Biotech, Inc.
13915- 96 Street, Edmonton, Alberta, Canada T5E5Z1
Date of filing: Dec 5, 2014
GRAS Notice (releasable information): 551
Date of closure / FDA's Letter: Mar 26, 2015
FDA has no questions